Predict your next investment

Venture Capital
eos.global

See what CB Insights has to offer

Investments

1

About EOS Global

EOS Global is a venture fund investing in entrepreneurs and developers leveraging EOSIO technology, to create a more efficient and aligned society.

EOS Global Headquarter Location

18 Lyndhurst Terrace

Central,

Hong Kong

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest EOS Global News

EOS developer Block.one helping build coronavirus testing app

Apr 29, 2020

EOS developer Block.one helping build coronavirus testing app Created in partnership with the Telos Foundation, the Agerona app will provide access to low-cost coronavirus tests. The blockchain-based company is co-developing an app for COVID-19 testing. Block.one, which purportedly raised $4 billion in an ICO, is also supporting other health-tech companies. Block.one, the company behind the EOS blockchain, announced today that it has awarded a $50,000 grant to blockchain company Genobank.io to help facilitate the development of an app to aid with novel coronavirus (COVID-19) testing. The open-source app, called Agerona, is being developed in collaboration with the Telos Foundation. Once available in May, it will allow users to source low-cost COVID-19 tests and then have their results available via the Telos blockchain, where they can choose to share it with medical professionals and even researchers as desired. The grant was awarded via Block.one’s EOS VC Grants program in partnership with FinLab EOS VC and EOS Global. “As an EOS VC Grants recipient, we are grateful to have the backing and support of Block.one’s venture arm EOS VC in aiding our efforts to anonymized DNA/RNA test kits (including coronavirus), while empowering patients and users to decide if they want their anonymized data to be available to the scientific community and help control the spread of the coronavirus and potentially contribute to a treatment,” said Genobank.io CEO Daniel Uribe, in a release. Block.one is the company behind purportedly the richest initial coin offering (ICO) to date at $4 billion, which resulted in a $24 million fine levied by the SEC. The company is trying to put some of that money to good use: beyond Genobank.io, Block.one has also invested in other blockchain health-tech companies. Health and wellness platform PUML and research company Innoplexus have both pivoted to assist with coronavirus-related needs of late, according to a Block.one release. “We’ve witnessed the growth of an open source community whose passion and innovation have helped to identify and solve critical business problems in sectors ranging from art to wellness,” said Block.one CEO Brendan Blumer, in a release. “With the onset of urgent world issues caused by the coronavirus, it is important that we empower and support the ways that blockchain technology is being applied to provide solutions.” Many other blockchain-based and decentralized projects have also been working to aid in COVID-19 recovery and release, ranging from IBM’s blockchain network for suppliers to a symptom-tracking app and even the long-running Folding@home , which is now harnessing the power of one million remote PCs to help find coronavirus remedies. https://decrypt.co/27075/eos-developer-block-one-helping-build-coronavirus-testing-app

EOS Global Investments

1 Investments

EOS Global has made 1 investments. Their latest investment was in Cryptobridge Capital as part of their Seed VC on June 6, 2020.

CBI Logo

EOS Global Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/18/2020

Seed VC

Cryptobridge Capital

$2M

Yes

Date

6/18/2020

Round

Seed VC

Company

Cryptobridge Capital

Amount

$2M

New?

Yes

Co-Investors

Sources

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.